Symbol Lookup

Wednesday April 23, 2014 8:38 PM ET. Data delayed 15 minutes.
0.00
0.00 (0.00%)
Bid/Lots
0.00/100
Ask/Lots
0.00/100
Open/Prev Close
0.00/0.00
Day Range
-----
52-Week Range
0.00-0.02
Vol/Avg Daily Vol
0.0/6.8K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
No documents available

Company Information

Dermisonics, Inc. (formerly Second Stage Ventures, Inc.) is a development stage company. The Company's principal activity is to provide drugs delivery system. Its Transdermal systems deliver drugs through the skin into the bloodstream. Medications delivered via skin patches avoid liver metabolism, a necessary feature for drug molecules to metabolize easily, and allows for lower dosing of medications. There are two types of transdermal delivery systems: passive and active. In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Active patches require a physical force to facilitate the movement of drug molecules across the skin. It is a development stage company.

CONTACT INFORMATION

HeadquartersSuite 400, 2360 Corporate Circle
IRVINE, CA, United States 89074
Phone647-426-1640
Fax--

EXECUTIVE OFFICERS

Chairman of the Board, Interim Chief Executive Officer, Interim Chief Financial OfficerBruce Haglund
DirectorGrant Atkins
DirectorBruce Redding

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$159.8KBeta-3.84
Revenue (TTM)--EPS--
Shares Out.63.9MBook Value$0.32
Dermisonics Inc does not pay a dividend.P/E--
Price/Sales (TTM)--
P/Cash Flow (TTM)--
Operating Margin--

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample